ZNF846
Zinc finger protein 846
Also known as: ZN846_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q147U1
- Gene
- ZNF846
- Ensembl
- ENSG00000196605
- Chromosome
- 19
- Canonical length
- 533 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Actin filaments
OverviewNCBI Gene
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
533 residues, UniProt reviewed canonical sequence.
>Q147U1|ZNF846
1 MDSSQHLVTF EDVAVDFTQE EWTLLDQAQR DLYRDVMLEN YKNLIILAGS ELFKRSLMSG
61 LEQMEELRTG VTGVLQELDL QLKTKGSPLL QDISAERSPN GVQLERSNTA EKLYDSNHSG
121 KVFNEHPFLM THMITHIGEK TSEDNQSGKA LRKNFPHSFY KKSHAEGKMP KCVKHEKAFN
181 QFPNLTRQNK THTQEKLCEC KDCWRTFLNQ SSLKLHIRSH NGDKHYVCKE CGKAFSNSSH
241 LIGHGRIHSG EKPYVCKECG KAFTQSTGLK LHIRTHSGEK PYKCKECGKA FTHSSYLTDH
301 TRIHSGKKPY VCMECGKAFT RSTGLILHMR IHTGEKPYEC KECGKAFIHS SYLTKHVRIH
361 SGEKLYLCKA CGKAFTRSSG LVLHMRTHTG EKPYECKECG KAFNNSSMLS QHVRIHTGEK
421 PYECKECGKA FTQSSGLSTH LRTHTGEKAC ECKECGKAFA RSTNLNMHMR THTGEKPYAC
481 KECGKAFRYS TYLNVHTRTH TGAKPYECKK CGKNFTQSSA LAKHLRTKAC EKTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ZNF846 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.46
- Highest tissue expression
- 18 nTPM
Expression across tissuesHPA
Tissue
- seminal vesicle: 18 nTPM
- urinary bladder: 14 nTPM
- testis: 13 nTPM
- ovary: 11 nTPM
- prostate: 11 nTPM
- endometrium: 10 nTPM
Single-cell type
- late primary spermatocytes: 492 nCPM
- early spermatids: 202 nCPM
- microglia: 165 nCPM
- podocytes: 149 nCPM
- sertoli cells: 142 nCPM
- papillary tip epithelial cells: 119 nCPM
Immune cell
- myeloid DC: 6.9 nTPM
- naive B-cell: 5.3 nTPM
- plasmacytoid DC: 4.4 nTPM
- memory CD8 T-cell: 4.2 nTPM
- memory B-cell: 4.1 nTPM
- naive CD8 T-cell: 3.9 nTPM
Brain region
- midbrain: 32 nTPM
- white matter: 31 nTPM
- medulla oblongata: 30 nTPM
- spinal cord: 30 nTPM
- amygdala: 29 nTPM
- thalamus: 29 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.89
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.81
- DepMap mean gene effect
- 0.16
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II transcription regulatory region sequence-specific DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ZNF846 as an antibody target. Whether an autoantibody or antibody against ZNF846 could matter depends on whether native ZNF846 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ZNF846 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ZNF846 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...